Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...

Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and ...

Medical imaging foundation models are ushering in a new era for precision oncology. By integrating massive multimodal ...

Surging cancer prevalence, expanding AI-powered diagnostics, and major healthcare digitalization initiatives accelerate the global AI in oncology market growth at a CAGR of 26.23% through 2032.Austin, ...

Request To Download Free Sample of This Strategic Report @ Market Valuation and Growth Projection: In 2019, the global cancer biomarkers market was valued at $10,944.08 million. Projections indicate ...

Sophia Genetics (SOPH) announced a collaboration with Complete Genomics, a company dealing in genomic sequencing, to launch and co-market ...

National Natural Science Foundation of China (No. 82472062); Regional Innovation and Development Joint Fund of the National Natural Science Foundation of China (No. U22A20345); National Science and ...

A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.

An NYC Health + Hospitals/Elmhurst (N.Y). team recently performed the system’s first stereotactic radiosurgery treatment using Varian’s TrueBeam linear accelerator. The hospital’s linear accelerator ...

Request To Download Free Sample of This Strategic Report @ Market Overview: The global immuno-oncology assay market was valued at $2,769.50 million in 2018, and it is projected to reach $6,179.20 ...

At the 2025 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium, Meara explored the ...

GenomOncology today announced a strategic partnership with the Glioblastoma Foundation to transform genomic testing for the nation's most aggressive brain cancer, glioblastoma. The collaboration ...